Metraipolis › archive › dc_32dc2064d8da

Apaziquone — Wikipedia (en)

Source
Wikipedia (en)
Original
https://en.wikipedia.org/wiki/Apaziquone
License (as archived)
CC-BY-SA-4.0
Archived
2026-11-09T16:40:17.060Z
SHA-256 of the archived text
005c2f8725a6c2126cdc8de36229aab5dd89e6ea429c33791dda5a7e4d8e9942
Stable URL of this page
https://metraipolis.com/documento/dc_32dc2064d8da

How to cite

Apaziquone — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Apaziquone (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_32dc2064d8da (Metraipolis archive dc_32dc2064d8da, sha256 005c2f8725a6c2126cdc8de36229aab5dd89e6ea429c33791dda5a7e4d8e9942)
BibTeX
@misc{dc32dc2064d8da,
  title = {Apaziquone — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/Apaziquone},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_32dc2064d8da; sha256 005c2f8725a6c2126cdc8de36229aab5dd89e6ea429c33791dda5a7e4d8e9942},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Apaziquone. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Apaziquone (tentative trade name EOquin) is an indolequinone that is a bioreductive prodrug similar to the older chemotherapeutic agent mitomycin C. In hypoxic cells, such as those on the inner surface of the urinary bladder, apaziquone is converted to active metabolites by intracellular reductases. The active metabolites alkylate DNA and lead to apoptosis. This activity is preferentially expressed in neoplastic cells. After administration of apaziquone directly into the urinary bladder (intravesically), the drug and its active metabolite were not detected in plasma, and there were no systemic side effects. Apaziquone has been applied in clinical studies sponsored by Spectrum Pharmaceuticals and Allergan for the treatment of superficial (non-muscle invasive) bladder cancer. Approximately 70% of all newly diagnosed patients with bladder cancer have non-muscle invasive bladder cancer and over one million patients in the United States and Europe are affected by the disease. The U.S. Food and Drug Administration (FDA) has granted Fast Track review status to apaziquone for this indication. In 2016, FDA issued a complete response letter informing the company that its new drug application for apaziquone in bladder cancer would not be approved.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «Apaziquone» — https://en.wikipedia.org/wiki/Apaziquone
Wikidata Q4779259: «composto chimico» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q4779259
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Apaziquone?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1329241691, consultata il 2026-11-09T16:37:24.505Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 50171d963c61f11a2f22ec2166f04ff20faf03a214e19412130af2bd66662727